Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 4/2018

18.11.2017

Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group

verfasst von: Andrej Lyshchik, Yuko Kono, Christoph F. Dietrich, Hyun-Jung Jang, Tae Kyoung Kim, Fabio Piscaglia, Alexander Vezeridis, Juergen K. Willmann, Stephanie R. Wilson

Erschienen in: Abdominal Radiology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Contrast-enhanced ultrasound (CEUS) is a specific form of ultrasound imaging performed with intravenous administration of microbubble contrast agents. It has been extensively used for liver tumor characterization and was recently added to the American College of Radiology Liver Imaging Reporting and Data System (CEUS LI-RADS). This paper describes technical recommendations for successful liver CEUS lesion characterization, and provides imaging protocol and Lexicon of imaging findings.
Literatur
1.
2.
Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (liver imaging reporting and data system): summary, discussion, and consensus of the LI-RADS management working group and future directions. Hepatology. 61:1056–1065CrossRefPubMed
3.
4.
Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51(6):2020–2029CrossRefPubMed
5.
Li R, Yuan MX, Ma KS, et al. (2014) Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. PLoS ONE 9(5):e98612CrossRefPubMedPubMedCentral
6.
Wildner D, Bernatik T, Greis C, et al. (2015) CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial. Ultraschall Med 36(2):132–139CrossRefPubMed
7.
Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699CrossRefPubMed
8.
Park YN (2011) Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med 135:704–715CrossRefPubMed
9.
10.
International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef
11.
Roskams T, Kojiro M (2010) Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis. 30:17–25CrossRefPubMed
12.
Trevisani F, Cantarini MC, Wands JR, Bernardi M (2008) Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 29:1299–1305CrossRefPubMed
13.
Chou CT, Chou JM, Chang TA, et al. (2013) Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol 19:7433–7439CrossRefPubMedPubMedCentral
14.
Jha RC, Mitchell DG, Weinreb JC, et al. (2014) LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. AJR Am J Roentgenol 203:48–69CrossRef
15.
Choi J-Y, Lee J-M, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma. Part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefPubMedPubMedCentral
16.
Han J, Liu Y, Han F, et al. (2015) The degree of contrast washout on contrast-enhanced ultrasound in distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Ultrasound Med Biol 41(12):3088–3095CrossRefPubMed
17.
Wildner D, Pfeifer L, Goertz RS, et al. (2014) Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma. Ultraschall Med 35(6):522–527CrossRefPubMed
18.
19.
Kono Y, Cosgrove D, Dietrich C, et al. (2016) Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosis of hepatocellular carcinoma: initial proposal. J Ultrasound Med 35(suppl):S1–S132
20.
Jang HJ, Kono Y, Sirlin C, et al. (2015) Incorporation of CEUS Into LI-RADS for diagnosis of hepatocellular carcinoma (HCC): a work in progress. Radiological Society of North America Annual Meeting. 29 November–4 December 2015, Chicago, IL. GI212-ED-X
21.
Piscaglia F, Wilson SR, Lyshchik A, et al. (2017) American college of radiology contrast enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: a pictorial essay. Ultraschall Med. 38:320–324CrossRefPubMed
22.
23.
24.
Claudon M, Dietrich CF, Choi BI, et al. (2012) A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013(39):187–210
25.
Sawhney S, Wilson SR (2017) Can ultrasound with contrast enhancement replace nonenhanced computed tomography scans in patients with contraindication to computed tomography contrast agents? Ultrasound Q 33:125–132CrossRefPubMedPubMedCentral
26.
Jang HJ, Kim TK, Burns PN, Wilson SR (2015) CEUS: an essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma. Eur J Radiol 84:1623–1635CrossRefPubMed
27.
Hanna RF, Miloushev VZ, Tang A, et al. (2016) Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol (NY) 41:71–79CrossRef
28.
Exuzides A, Main ML, Colby C, et al. (2010) A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging 3:578–585CrossRefPubMed
29.
Goldberg YH, Ginelli P, Siegel R, et al. (2012) Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk. Cardiology 122(2):119–125CrossRefPubMed
30.
Aggeli C, Giannopoulos G, Roussakis G, et al. (2008) Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies. Heart 94:1571–1577CrossRefPubMed
31.
Parker JM, Weller MW, Feinstein LM, et al. (2013) Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol 1(112):1039–1045CrossRef
32.
Jo PC, Jang HJ, Burns PN, et al. (2017) Integration of Contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how i do it. Radiology 282:317–331CrossRefPubMed
33.
EFSUMB (2010) Minimum training requirements for the practice of medical ultrasound in Europe. Ultraschall in Med 31:426–427CrossRef
34.
35.
Main ML, Hibberd MG, Ryan A, et al. (2014) Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging 7:40–48CrossRefPubMed
36.
Parker JM, Weller MW, Feinstein LM, et al. (2013) Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol 112:1039–1045CrossRefPubMed
37.
Main ML, Ryan AC, Davis TE, et al. (2008) Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol. 102:1742–1746CrossRefPubMed
38.
Wei K, Mulvagh SL, Carson L, et al. (2008) The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 21:1202–1206CrossRefPubMed
39.
Herzog CA (2008) Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA 299:2023–2025CrossRefPubMed
40.
41.
42.
43.
44.
Yu H, Jang HJ, Kim TK, et al. (2010) Pseudo-enhancement within local ablation zone of hepatic tumors due to nonlinear artifact on contrast-enhanced ultrasound. Am J Roentgenol 194:653–659CrossRef
45.
Dietrich CF, Ignee A, Greis C, et al. (2014) Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. Ultraschall Med 35(2):108–125CrossRefPubMed
46.
Li SY, Huang P, Cosgrove D, et al. (2016) Pseudoenhancement of gallbladder sludge: a confusing artifact caused by nonlinear propagation of ultrasound through microbubbles. Ultraschall Med 37(3):307–309CrossRefPubMed
47.
48.
Hanna RF, Aguirre DA, Kased N, et al. (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28:747–769CrossRefPubMed
Metadaten
Titel
Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group
verfasst von
Andrej Lyshchik
Yuko Kono
Christoph F. Dietrich
Hyun-Jung Jang
Tae Kyoung Kim
Fabio Piscaglia
Alexander Vezeridis
Juergen K. Willmann
Stephanie R. Wilson
Publikationsdatum
18.11.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1392-0

Weitere Artikel der Ausgabe 4/2018

Abdominal Radiology 4/2018 Zur Ausgabe

OriginalPaper

Artifacts in contrast-enhanced ultrasound: a pictorial essay

Invited article

Machine learning for medical ultrasound: status, methods, and future opportunities

Pictorial essay

Contrast-enhanced ultrasound (CEUS) in abdominal intervention

OriginalPaper

Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology

Pictorial essay

Hypervascular pancreatic “lesions”: a pattern-based approach to differentiation

Pictorial essay

Contrast-enhanced ultrasound (CEUS) of the abdominal vasculature

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet

29.03.2024 | Diagnostische Radiologie | Nachrichten

Studie bestätigt Potenzial von KI in der Radiologie
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen